Nima Almassi, MD

Almassi's primary research interest is in bladder cancer, focused primarily on the impact of variant histology on treatment outcomes in patients with non-muscle-invasive bladder cancer treated with intravesical therapy and patients with muscle-invasive bladder cancer treated with neoadjuvant systemic therapy and radical cystectomy; the impact of body morphometry on clinical outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant systemic therapy and radical cystectomy; and oncologic and quality of life outcomes with less radical surgical approaches including vaginal-sparing cystectomy in women, nerve-sparing cystectomy in men, and a clinical trial evaluating partial cystectomy in the treatment of select patients with muscle-invasive bladder cancer. This work includes observational studies as well as prospective clinical trials.